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Abstract Prohibitin is a ubiquitously expressed protein with 
antiproliferative properties. When rat prohibitin tagged with a 
carboxy-terminal c-Myc epitope was expressed in baby hamster 
kidney cells the protein was targeted to mitochondria. In im- 
munofluorescence microscopy prohibitin colocalized with a mito- 
chondrial marker E3. lmmunoelectron microscopy revealed that 
prohibitin was associated with the periphery of mitochondria. The 
amino-terminus of prohibitin shares characteristics of the known 
mitochondrial import signals, and positioning of the tag at the 
N-terminus causes accumulation of the protein in the cytoplasm. 
These findings help to direct functional studies on prohibitin and 
suggest hat a mitochondrial protein may act as a tumor suppres- 
sor. 
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1. Introduction 
The prohibitin gene was isolated for its ability to negatively 
regulate cell proliferation. McClung et al. [1] cloned it as one 
of the cDNAs derived from mRNAs which were more highly 
expressed in nondividing than regenerating rat liver ceils. The 
antiproliferative activity of prohibitin could be demonstrated 
by microinjection of the synthetic mRNA into normal fibro- 
blasts and HeLa cells where it blocked the entry of cells into 
S phase [2]. Prohibitin mRNA expression levels of cultured 
fibroblasts were found to vary 3- to 4-fold with culture condi- 
tions and cell cycle state [3]. However, the mRNA was ex- 
pressed at roughly comparable vels in all tested rat tissues [2]. 
The mRNA codes for a protein of 272 amino acids. No 
protein motifs typical for signal sequences, nuclear localization 
signals, ATP-binding sites or transcription factors could be 
identified in the primary structure. A short, 12 residue stretch 
at the N-terminus was the longest hydrophobic region found 
in the protein. When the mRNA was translated in vitro it 
produced apolypeptide ofthe expected length of about 30 kDa, 
but this was not translocated into microsomes. Consequently, 
the in vitro translated protein was not modified by sugar addi- 
tion or signal peptide cleavage [2]. In cultured cells, the prohib- 
itin protein was found not to reflect directly the variable 
amounts of mRNA at different stages of the cell cycle, but was 
rather constitutively expressed with 2- to 3-fold higher levels in 
rapidly dividing than senescent cells [4]. We have identified a
protein of similar molecular weight and isoelectric point in a 
detergent insoluble cellular membrane fraction from dog kid- 
ney epithelial cells. Two tryptic peptide sequences 
(ILFRPVASQLPR and IYTSIGEDY) obtained from the pro- 
tein purified from two- dimensional gels [5, protein A26] 
matched with the published rat sequence and confirmed this 
protein to be prohibitin. 
Prohibitin was found to share substantial homology with a 
Drosophila protein, Cc, of unknown function but vital for nor- 
mal development and differentiation [2]. Flies homozygous for 
nonfunctional Cc alleles die during the larva to pupa metamor- 
phosis [6]. The protein seems to be well conserved, as the clon- 
ing of the human prohibitin gene revealed only a single amino 
acid difference to the rat sequence [7]. Interestingly, the human 
gene maps to chromosome 17q21, a region commonly deleted 
in breast tumors [8]. Moreover, in a substantial fraction of 
sporadic human breast cancers howing loss of heterozygosity 
on the long arm of chromosome 17 or developed in patients 
35 years old or younger mutations in the prohibitin gene were 
identified [7], strengthening the argument of the antiprolifera- 
tive or tumor suppressive nature of prohibitin. The mechanism 
by which the antiproliferative activity of prohibitin is mediated 
remains, however, unknown. As one of the first steps towards 
understanding the function of prohibitin we investigated its 
subcellular localization. 
2. Materials and methods 
2.1. Construction fthe tagged prohibitin cDNAs 
To generate a construct with an N-terminal c-Myc epitope 
EQKLISEEDL [9], the wild type rat prohibitin cDNA in the Bluescript 
plasmid [2] was amplified by PCR with the following oligonucleotides: the
5' mutagenic primer (5'CAGGTGGATCCATGGAACAAAAACTC- 
ATCTCAGAAGAGGATCTGATGGCTGCCAAAGTGTTTGAGT- 
CC3') encoding the amino acids MEQKLISEEDL preceded by a 
BamHI site and followed by the first eight amino acids of prohibitin, 
and the 3' primer (5'ACGAGGAAGCTGGCTGGCCACCGGCCG- 
GAA3'). The PCR product was digested with BamHI and EagI and 
ligated into EagI-HindlII cut prohibitin providing the rest of the coding 
region and BamHI-HindlII cut pBluescript. Thus, the 5' end of the 
construct containing the tag just upstream the initiator methionine 
faces the T7 promoter of the plasmid. To add the c-Myc tag to the 
C-terminus the prohibitin cDNA was amplified with the 5' primer 
(5'GAAGCAGAGAGAGCCAGATTTGTGGTGGAA3') and the Y 
mutagenic primer encoding the amino acids EQKLISEEDL after the 
last amino acid of prohibitin and a HindlII cloning site (5'CGATCC- 
GAAGCTTTTACAGATCCTCTTCTGAGATGAGTTTTTGTTCC- 
TGGGGGAGCTGGAGGAGCACY). The PCR product digested 
with XcmI and HindlII was ligated into BamHI-XcmI cut prohibitin 
and BamHI-HindllI cut pBluescript. All the regions generated by PCR 
were confirmed by sequencing to be correct. 
*Corresponding author. Fax: (49) (6221) 387 306. 
Abbreviations: cDNA, complementrary DNA; PCR, polymerase chain 
reaction; BHK, baby hamster kidney; FCS, fetal calf serum; PBS, 
phosphate-buffered saline; SDS-PAGE, sodium dodecyl sulphate-poly- 
acrylamide gel electrophoresis. 
2.2. Cell culture and transfection 
BHK 21 cells were grown in Glasgow's modified Eagle's medium 
supplemented with 5% FCS, 10% tryptose phosphate broth, 2 mM 
glutamine, 100 U/ml penicillin, and 10/tg/ml streptomycin. The cells 
grown on cover slips were 80% confluent on the day of transfection. The 
cells were washed with serum-free medium and infected with T7 RNA 
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polymerase-recombinant vaccinia virus [10] using 3-5 pfu/cell. The 
infection was carried out at room temperature for 30 rain, after which 
the cells were transfected with the 5' or 3' myc-tagged prohibitin plas- 
mids using DOTAP reagent (Bcehringer Mannheim GmbH) according 
to the manufacturer's instructions. After 4 h incubation at 37°C 5% 
CO2, cycloheximide (20/~g/ml) was added to the cells and the expression 
continued for additional 1.5-2 h before fixation. 
2.3. Immunofluorescence microscopy 
The cells were fixed with 4% paraformaldehyde in PBS for 20 min 
and after rinsing with PBS incubated in ice-cold methanol for 5 min at 
- 20 °C. After fixation the ceils were washed with PBS and the aldehyde 
groups quenched with 50 mM NHaC1 in PBS for 15 min followed by 
PBS wash. The cells were permeabilized with 0.1% Triton X-100 for 
4 rain, washed with PBS and unspecific antibody binding was blocked 
by incubating the cells in 10% heat-inactivated FCS for 30 min. The 
purified ascites olution of the monoclonal antibody 9El0 against he 
human c-Myc epitope was diluted 1 : 1000 and the polyclonal anti-E3 
antibody 1:200 in 5% FCS. The mouse cell line producing 9El0 was 
purchased from the European Collection of Animal Cell Cultures (no. 
85102202). The anti-E3 antibody was a kind gift from Dr. Masatoshi 
Hakozaki (Fukushima Medical College, Fukushima, Japan). The cells 
were incubated 30 min at room temperature with the primary antibod- 
ies, washed effectively with PBS and the primary antibodies visualized 
with pre-adsorbed tetramethyl rhodamine isothiocyanate-conjugated 
donkey anti-mouse or fluorescein isothiocyanate-conjugated donkey 
anti-rabbit antibodies (Dianova, Hamburg, Germany). The cover slips 
mounted in Moviol were viewed and photographed with an Axiophot 
photomicroscope (Carl Zeiss, Oberkochen, Germany). 
2.4. Immunoelectron microscopy 
BHK cells were transfected as described above except hat the trans- 
fection time was increased to 6.5 h and incubation with cycloheximide 
omitted to maximize the number of cells transfected. After fixation in 
8% paraformaldehyde in 250 mM HEPES, pH 7.35, the cells were 
scraped from the culture dish, pelleted, and processed for cryosection- 
ing as described previously [11]. Thawed sections were labeled by se- 
quential incubations with the 9El0 culture supernatant, followed by 
secondary antibody and 10 nm protein A-gold. The distribution of gold 
particles associated with mitochondrial profiles was ascertained on 
micrographs taken at a primary magnification of20 k x. Gold particles 
associated with 30 mitochondrial profiles were classified as (a) periph- 
eral (within 30 nm of the periphery of the mitochondria), (b) associated 
with the cristae (within 30 nm of the membranes of the cristae), 
(c) within the matrix, and (d) other (position unclear). 
2.5. Western blotting 
BHK cells transfected with the 5' or 3' Myc-tagged prohibitin con- 
structs were lysed in 1% SDS and the proteins eparated by reducing 
12% SDS-PAGE. The proteins were transferred to nitrocellulose in a 
Fig. 1. Imrnunofluorescence localization of epitope tagged prohibitin. The T7 RNA polymerase - recombinant vaccinia virus expression system was 
used to express either C- or N-terminally Myc-tagged prohibitin in BHK cells and the overexpressed protein was immunostained using the 
Myc-antibody. In a cell expressing the C-terminally tagged prohibitin (A) the labeling colocalizes with the mitochondrial marker E3 (B), whereas 
cells expressing the N-terminally tagged prohibitin (C) show strong cytoplasmic immunoreactivity which does not colocalize with E3 (D). Bars, 
10/zm. 
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Fig. 2. Immunoelectron microscopy localization of epitope tagged prohibitin. BHK cells were transfected with C-terminally Myc-tagged prohibitin, 
processed for frozen sectioning and labeled as detailed in section 2. A, Labeling is associated with the peripheral membrane of mitochondria (m) 
but not with other membranes (e.g. the nuclear envelope, n). B-E, Labeling is predominantly present around the periphery of the mitochondria but 
some gold label (large arrowheads) is occasionally seen close to the cristae (small arrowheads). Bars, 100 nm. 
blotting buffer consisting of 25 mM Tris, 190 mM glycine and 20% 
methanol. The liter was incubated in a blocking solution (5% non-fat 
dried milk, 0.1% Tween 20 in PBS) for 1 h at room temperature b fore 
binding of the anti-myc 9El0 antibody (diluted 1 : 5000 in blocking 
solution) overnight at 4°C. The bands were detected by chemiluminis- 
cence using horseradish peroxidase-conjugated goat anti-mouse sec- 
ondary antibody (Jackson Immuno Research Inc.) and the ECL rea- 
gent (Amersham). 
3. Results and discussion 
To localize prohibitin intracellularly, we tagged the protein 
with the c-Myc epitope (EQKLISEEDL) either at the N- or the 
C-terminus. Two different locations for the tag were used to 
exclude possible mislocalizations that could be caused by the 
tag interfering with putative unknown targeting signals. The 
tagged proteins were overexpressed using the vaccinia T7 sys- 
tem in BHK cells, and visualized by the Myc-antibody. The 
staining obtained with the C-terminally tagged protein was 
punctate, in the form of fairly large dots as well as elongated 
structures, evenly distributed throughout the cytoplasm (Fig. 
1A). The shape, from round to tubular, and size of the labeled 
structures resembled mitochondrial staining. We therefore dou- 
ble-stained the infected BHK cells for prohibitin and E3, dihy- 
drolipoamide dehydrogenase, a component in the mitochon- 
drial 2-oxo acid dehydrogenase complexes (for review see [12]). 
The labelings colocalized precisely indicating that the C-termi- 
nally tagged prohibitin is indeed targeted to mitochondria (Fig. 
1A and B). The staining pattern remained identical regardless 
of the transfection time (3 to 7 h), except hat more cells ex- 
pressing prohibitin were found with increasing time (data not 
shown). 
When the N-terminally tagged prohibitin was expressed 
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Fig. 3. Amphiphilic helix formed by the N-terminus of prohibitin. 
Amino-terminal residues 1-18 were plotted on a 'helical wheel' as de- 
scribed by Schiffer and Edmundson [17]. The hydrophobic residues are 
marked with rectangles and the positively charged ones are encircled. 
using the same system the staining pattern was, surprisingly, 
completely different. The protein was found to accumulate in
the cytoplasm and showed no colocalization with the mitochon- 
drial marker E3 (Fig. 1C and D). In preliminary experiments 
where cells were fixed with paraformaldehyde and permeabil- 
ized with Triton X-100, the cytoplasmic staining was weak (not 
shown). However, fixation of proteins with both paraformalde- 
hyde and methanol prevented the antigen from being washed 
away during the staining and allowed the detection of the dif- 
fuse cytoplasmic accumulation of the antigen. 
To extend the immunofluorescence microscopic localization 
of the C-terminally tagged prohibitin we carried out immuno- 
electron microscopy with the Myc-antibody on ultrathin frozen 
sections of transfected BHK cells. The antibody labeled specif- 
ically only the mitochondria of prohibitin expressing cells (Fig. 
2A). There was no significant labeling of other membranes in
transfected cells and there was no mitochondrial labeling in 
untransfected cells. In the transfected cells the labeling was 
predominantly present around the periphery of the mitochon- 
dria (Fig. 2A-E). When the distribution of gold particles asso- 
ciated with mitochondrial profiles was quantitated (see section 
2 for details) 78% of the labeling was found to be peripheral, 
15% associated with cristae and only 3% within the mitochon- 
drial matrix. In 4% the position of gold particles remained 
unclear. The fraction of peripheral labeling may be underesti- 
mated as a glancing section across the periphery of a mitochon- 
drion may reveal apparent intramitochondrial l beling. The 
immunoelectron microscopic localization of prohibitin leaves 
still open whether the protein is associated with either of the 
mitochondrial membranes or with the intermembrane space. 
However, it rules out the possibility that prohibitin would be 
a matrix protein. Although prohibitin is mostly hydrophilic, 
membrane association of the protein is not excluded as the 
N-terminal hydrophobic stretch may be long enough to form 
a membrane span [13]. 
Most proteins directed into mitochondria (whether the final 
location of the protein will be in the mitochondrial matrix, 
inner membrane or intermembrane space) carry an N-terminal 
cleavable presequence ontaining the mitochondrial targeting 
signal. This signal is short (about 8-30 amino acids) and has 
a tendency to form an amphiphilic a-helix upon insertion into 
lipid membranes [14,15]. The unusual properties of an am- 
phiphilic helix result from the uneven distribution of hydropho- 
bic and hydrophilic residues around the helix. The presequence 
usually contains everal positively charged and hydroxylated 
residues and few, if any, negative charges. The positively 
charged amino acids and the hydrophobic residues are facing 
opposite sides of the helix (for review see [16]). As presequences 
have no obvious primary structure homology it is difficult to 
predict a mitochondrial localization of a protein from the se- 
quence alone. Interestingly, if the 18 N-terminal residues of 
prohibitin are plotted on a helical wheel [17] the hydrophobic 
and uncharged residues are clustered on one side, whereas the 
positively charged amino acids are on the opposite side 
(Fig. 3). Moreover, if the c-Myc epitope is inserted at the N- 
terminus, 3 additional negative charges will be introduced and 
the amphiphilic helix will be broken. Thus, the sequence analy- 
ses agree well with our findings, the N-terminal sequence of the 
wild type prohibitin favoring mitochondrial import and the 
N-terminal tag blocking entry. 
To visualize the prohibitin polypeptide chains we analyzed 
the overexpressed proteins from BHK cell lysates by Western 
blotting with the Myc-antibody. Both tagged constructs gave 
rise to protein products of the expected size. However, there 
was a small but reproducible migration difference between the 
two proteins, the protein tagged at the C-terminus howing a 
slightly faster mobility on SDS-PAGE than the N-terminally 
tagged one (Fig. 4). In view of the mitochondrial localization 
of the C-terminally tagged prohibitin, it is likely that an 
N-terminal targeting signal is cleaved from the protein follow- 
ing mitochondrial import. However, we cannot exclude the 
possibility that the position of the tag causes a conformational 
difference affecting the apparent mobility of the polypeptide 
chains on SDS-PAGE. 
The data unambigously demonstrate hat the C-terminally 
epitope tagged and overexpressed prohibitin is targeted to mi- 
tochondria. The possibilities of creating a new artificial C- 
terminal mitochondrial import signal by the tagging or causing 
false import into mitochondria due to overexpression seem very 
unlikely. Furthermore, the mitochondrial localization of pro- 
hibitin is in accordance with several previous observations. The 
protein is constitutively expressed in a wide variety of cell types 
and the highest protein levels are found in rapidly proliferating 
cells. The protein is intracellular but is not translocated into 
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Fig. 4. Immunoblot analysis of prohibitin expression i BHK cells. 
Proteins from BHK cells expressing either the C-terminally (1) or 
N-terminally (2) Myc-tagged prohibitin or untransfected cells (3) were 
probed with the Myc-antibody. The C-terminally tagged prohibitin has 
a slightly smaller apparent molecular weight han the N-terminally 
tagged one. A nonspecific band of about 40 kDa is recognized by the 
antibody in transfected as well as in untransfected cells. 
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microsomes, nor does it have a clear signal sequence. Hence, 
prohibitin falls into the same category as most mitochondrial 
proteins, being synthesized on cytosolic polysomes and trans- 
ported into the organelle. The recent finding that prohibitin 
associates with the mlgM antigen receptor in B-lymphocytes a
judged by coprecipitation of prohibitin with mlgM in cell ly- 
sates [18] is difficult o interpret in the light of our results. More 
data are clearly necessary to accomodate hese findings with the 
function of prohibitin. 
The intriguing question raised by our findings is how the 
mitochondrial localization of prohibitin is related to its putative 
tumor suppressor activity. Whatever the mechanism of action 
of prohibitin, ultimately, to act as an antioncogene, it should 
lead to transduction ofan inhibitory signal for cell division. The 
strongest evidence for a link between the function of the prohib- 
itin gene product and development and/or progression of neo- 
plasia comes from a case of sporadic breast carcinoma where 
it was obvious that in the tumor cells neither of the alleles could 
produce a normal prohibitin protein [7]. Provided that this 
biallelic loss of function plays a role in the pathogenesis of 
breast cancer prohibitin would be the first mitochondrially 
localized protein acting as a tumor suppressor. 
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